Mark Griso Mark has thirty-five years experience in international Regulatory Affairs and CMC development and has broad knowledge of legislation, guidelines and specific requirements for registration of NCEs, in many therapeutic areas, particularly oncology.
Mark has worked in strategic R&D development in defining optimum filing strategy and taking many compounds from ‘Proof of Concept’ through to registration.
He has strong regulatory interactions with many Health Agencies.
Until joining On-kos Mark was worldwide Head of Regulatory Affairs Oncology for Pfizer Inc.